Skip to content
ppharmaranks
Menu
Class IOngoing

Dextrose Injection recall

FDA recall D-0850-2026 · initiated Aug 17, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Sep 16, 2026How we research

Baxter Healthcare Corporation recalled Dextrose Injection in Aug 2026 — an FDA Class I recall (D-0850-2026) because Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

Most serious — a reasonable probability that use will cause serious harm or death.

Why it was recalled

Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #: Y495066, Exp. Date July 31, 2027

Quantity recalled: 606 bags

Details

Product
Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06
Recalling company
Baxter Healthcare Corporation
Classification
Class I
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
U.S. Nationwide.
Initiated
Aug 17, 2026
FDA report date
Sep 16, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Dextrose Injection recalled?
Baxter Healthcare Corporation recalled Dextrose Injection in Aug 2026 — an FDA Class I recall (D-0850-2026) because Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution. Most serious — a reasonable probability that use will cause serious harm or death.
Why was Dextrose Injection recalled?
Per the FDA enforcement record, the reason for recall D-0850-2026 was: Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
Is a recalled Dextrose Injection dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Dextrose Injection are affected?
Distributed: U.S. Nationwide.. The recall covers these lots — Lot #: Y495066, Exp. Date July 31, 2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0850-2026.

Source: openFDA Drug Enforcement record D-0850-2026 ↗

← All drug recalls